Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences

Overview

Journal Front Pharmacol

Date 2018 Dec 18

PMID 30555327

Citations 53

Authors

Bowen Fu

Ning Wang

Hor-Yue Tan

Sha Li

Fan Cheung

Yibin Feng

Affiliations

Soon will be listed here.

Abstract

Chemotherapy is nowadays the main treatment of human cancers. Chemotherapeutic agents target rapidly dividing cancer cells to suppress tumor progression, however, their non-specific cytotoxicity often leads to significant side effects that might be intolerable to cancer patients. Multi-component herbal products have been used for thousands of years for the treatment of multiple human diseases. This study aims to systematically summarize and evaluate the experimental and clinical evidences of the efficacy of multi-component herbal products in improving chemotherapy-induced side effect. Literature was retrieved from PubMed database and evaluated based on the side effects described. Multi-component herbal products were found to be effective in ameliorating the neurotoxicity, gastrointestinal toxicity, hematological toxicity, cardiotoxicity, hepatotoxicity and nephrotoxicity. Both experimental and clinical evidences were found, indicating the potential of applying multicomponent herbal products in the clinical treatment of chemotherapy-induced side effects. However, the lack of mechanistic and pharmacokinetic studies, inconsistency in product quality, as well as insufficient clinical evidence suggested that more investigations are urgently necessary. In all, our review shed light on the potential of using multi-component herbal products in the clinical management of chemotherapy-induced toxicity and side effects. We also discussed the potential threats of natural products for cancer treatment and compared the advantages of using herbs to conventional chemical drugs.

Citing Articles

Network pharmacology combined with molecular docking and experimental validation of the mechanism of action of columbianetin acetate in the treatment of ovarian cancer.

Hu M, Wang L, Zhang F, Xie Y, Zhang T, Liu H Front Oncol. 2025; 15:1515976.

PMID: 40071097 PMC: 11894577. DOI: 10.3389/fonc.2025.1515976.

Exosomes and SARS-CoV-2 infection.

Li L, Yang Z, Li J Front Immunol. 2024; 15():1467109.

PMID: 39660145 PMC: 11628517. DOI: 10.3389/fimmu.2024.1467109.

Efficacy of Thymoquinone and Hesperidin in Attenuating Cardiotoxicity from 5-Fluorouracil: Insights from In Vivo and In Silico Studies.

Farooq J, Sultana R, James J, Fathima C Z, Almutairy A, Hussain A Toxics. 2024; 12(9).

PMID: 39330616 PMC: 11435605. DOI: 10.3390/toxics12090688.

Effectiveness and safety of Chaihu-Shugan-San for treating depression based on clinical cases: An updated systematic review and meta-analysis.

Zhang X, Zhao Q, Wang Y, Mao Y, Sun Y, Bian X Medicine (Baltimore). 2024; 103(26):e38668.

PMID: 38941409 PMC: 11466128. DOI: 10.1097/MD.0000000000038668.

Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents.

Katolkar U, Surana S Curr Protein Pept Sci. 2024; 25(10):753-779.

PMID: 38919003 DOI: 10.2174/0113892037307940240606075208.

References

Mikalauskas S, Mikalauskiene L, Bruns H, Nickkholgh A, Hoffmann K, Longerich T . Dietary glycine protects from chemotherapy-induced hepatotoxicity. Amino Acids. 2010; 40(4):1139-50. DOI: 10.1007/s00726-010-0737-6. View

Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K . Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008; 134(7):2004-13. DOI: 10.1053/j.gastro.2008.02.078. View

Kono T, Kaneko A, Matsumoto C, Miyagi C, Ohbuchi K, Mizuhara Y . Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes. Integr Cancer Ther. 2014; 13(5):435-45. DOI: 10.1177/1534735413520035. View

Wadler S, Benson 3rd A, Engelking C, Catalano R, Field M, Kornblau S . Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol. 1998; 16(9):3169-78. DOI: 10.1200/JCO.1998.16.9.3169. View

Joy J, Nair C . Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract. J Cancer Res Ther. 2008; 4(3):111-5. DOI: 10.4103/0973-1482.43139. View

Ben-Arye E, Lavie O, Samuels N, Khamaisie H, Schiff E, Raz O . Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a "bedside-to-bench" approach. Med Oncol. 2017; 34(4):54. DOI: 10.1007/s12032-017-0910-9. View

Li Y, Hu J, Huang H, He Y . Effect of Jinlong capsule on proliferation and apoptosis of human pancreatic cancer cells BxPC-3. J Tradit Chin Med. 2013; 33(2):205-10. DOI: 10.1016/s0254-6272(13)60126-0. View

Ohnishi S, Watari H, Kanno M, Ohba Y, Takeuchi S, Miyaji T . Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02). J Gynecol Oncol. 2017; 28(5):e44. PMC: 5540714. DOI: 10.3802/jgo.2017.28.e44. View

Kawashiri T, Egashira N, Kurobe K, Tsutsumi K, Yamashita Y, Ushio S . L type Ca²+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol Pain. 2012; 8:7. PMC: 3285049. DOI: 10.1186/1744-8069-8-7. View

10.

Kebieche M, Lakroun Z, Lahouel M, Bouayed J, Meraihi Z, Soulimani R . Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration. Exp Toxicol Pathol. 2008; 61(2):161-7. DOI: 10.1016/j.etp.2008.06.002. View

11.

Aoyama T, Nishikawa K, Takiguchi N, Tanabe K, Imano M, Fukushima R . Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol. 2014; 73(5):1047-54. PMC: 4000413. DOI: 10.1007/s00280-014-2440-x. View

12.

Shiomi Y, Ohira Y, Yoshimura M, Ozaki T, Takei M, Tanaka T . Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a. Eur J Pharmacol. 2017; 818:148-157. DOI: 10.1016/j.ejphar.2017.10.047. View

13.

Konmun J, Danwilai K, Ngamphaiboon N, Sripanidkulchai B, Sookprasert A, Subongkot S . A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. Med Oncol. 2017; 34(4):69. DOI: 10.1007/s12032-017-0931-4. View

14.

Ohkawa K, Hashiguchi M, Ohno K, Kiuchi C, Takahashi S, Kondo S . Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients. Clin Pharmacol Ther. 2002; 72(2):220-6. DOI: 10.1067/mcp.2002.126175. View

15.

Dong J, Su S, Wang M, Zhan Z . Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. J Exp Clin Cancer Res. 2010; 29:137. PMC: 2972256. DOI: 10.1186/1756-9966-29-137. View

16.

Frenzel C, Teschke R . Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int J Mol Sci. 2016; 17(5). PMC: 4881436. DOI: 10.3390/ijms17050588. View

17.

Wang W, You R, Qin W, Hai L, Fang M, Huang G . Anti-tumor activities of active ingredients in Compound Kushen Injection. Acta Pharmacol Sin. 2015; 36(6):676-9. PMC: 4594177. DOI: 10.1038/aps.2015.24. View

18.

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402(6762):656-60. DOI: 10.1038/45230. View

19.

Schele E, Bake T, Rabasa C, Dickson S . Centrally Administered Ghrelin Acutely Influences Food Choice in Rodents. PLoS One. 2016; 11(2):e0149456. PMC: 4771210. DOI: 10.1371/journal.pone.0149456. View

20.

Bois A, Schlaich M, Luck H, Mollenkopf A, Wechsel U, Rauchholz M . Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care Cancer. 1999; 7(5):354-61. DOI: 10.1007/s005200050275. View